Wendy Lovvorn - Streamline Health Chief Officer
| STRM Stock | USD 4.60 0.30 6.98% |
Executive
Wendy Lovvorn is Chief Officer of Streamline Health Solutions
| Age | 52 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Wendy Lovvorn Latest Insider Activity
Tracking and analyzing the buying and selling activities of Wendy Lovvorn against Streamline Health stock is an integral part of due diligence when investing in Streamline Health. Wendy Lovvorn insider activity provides valuable insight into whether Streamline Health is net buyers or sellers over its current business cycle. Note, Streamline Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Streamline Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Wendy Lovvorn over a week ago Disposition of 11682 shares by Wendy Lovvorn of Streamline Health at 1.57 subject to Rule 16b-3 | ||
Wendy Lovvorn over two months ago Acquisition by Wendy Lovvorn of 170000 shares of Streamline Health at 1.75 subject to Rule 16b-3 |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1054) % which means that it has lost $0.1054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8009) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tia Padia | HealthEquity | N/A | |
| Jason Hahn | National Research Corp | 53 | |
| Megan Charko | National Research Corp | N/A | |
| RN BSN | HealthStream | 49 | |
| Daniel LeSueur | Health Catalyst | 47 | |
| Kevin OHara | HealthStream | 54 | |
| Jeffrey Selander | Health Catalyst | N/A | |
| Andy Monnich | National Research Corp | 49 | |
| Kamesh Tumsi | HealthEquity | N/A | |
| Daniel Orenstein | Health Catalyst | 54 | |
| Arthur Newman | HealthStream | 75 | |
| Kevin Freeman | Health Catalyst | 51 | |
| Ryan Barry | Health Catalyst | N/A | |
| Linda Stacy | National Research Corp | N/A | |
| Benjamin Landry | Health Catalyst | 43 | |
| Michael JD | HealthStream | 49 | |
| Christophe Louvion | National Research Corp | 52 | |
| Jason Holden | Forian Inc | N/A | |
| Leslie Falk | Health Catalyst | N/A | |
| Kyle Salyers | Health Catalyst | N/A | |
| Steve Lindsay | HealthEquity | N/A | |
Management Performance
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Lance Seach, Senior Development | ||
| Jawad Shaikh, Chief Officer | ||
| Benjamin Stilwill, Chief Officer | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Amy Sebero, Chief Officer | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| Bryant III, Chief Officer | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.93) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | 29.55 M | ||||
| Shares Outstanding | 4.27 M | ||||
| Shares Owned By Insiders | 24.21 % | ||||
| Shares Owned By Institutions | 20.37 % | ||||
| Number Of Shares Shorted | 28.08 K | ||||
| Price To Earning | 321.67 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.